Blueprint Medicines Corporation (0HOJ.L)
USD 97.85
(1.4%)
USD 97.85
(1.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -436.84 Million | -502.27 Million | -298.65 Million | 387.03 Million | -278.01 Million | -175 Million |
| Net Income | -506.98 Million | -557.51 Million | -644.08 Million | 313.88 Million | -347.69 Million | -236.64 Million |
| Depreciation & Amortization | 11.66 Million | 11.73 Million | 6.47 Million | 6.55 Million | 5.25 Million | 4.24 Million |
| Deferred income taxes | 23.2 Million | - | 1.36 Million | 466 Thousand | -4.94 Million | - |
| Stock-based compensation | 92.67 Million | 98.97 Million | 91.63 Million | 75.52 Million | 54.65 Million | 30.53 Million |
| Change in working capital | -41.12 Million | -53.76 Million | -23.68 Million | -15.61 Million | 9.72 Million | 31.24 Million |
| Other non-cash items | -16.27 Million | -1.69 Million | 269.64 Million | 6.22 Million | 4.99 Million | -4.38 Million |
| Investing Cash Flow | 274.04 Million | -149.54 Million | -225.86 Million | -434.24 Million | -16.46 Million | -161.08 Million |
| Investments in PPE | -16.06 Million | -8.91 Million | -261.24 Million | -3.15 Million | -14.01 Million | -12.67 Million |
| Acquisitions | - | - | 258.15 Million | 431.09 Million | 2.45 Million | - |
| Investment purchases | -766.36 Million | -489.7 Million | -655.44 Million | -969.43 Million | -738.38 Million | -801.23 Million |
| Sales/Maturities of investments | 1.05 Billion | 349.37 Million | 690.83 Million | 538.34 Million | 735.93 Million | 652.82 Million |
| Other Investing Activities | 1.00 | -290 Thousand | -258.15 Million | -431.09 Million | -2.45 Million | -148.41 Million |
| Financing Cash Flow | 119.22 Million | 561.81 Million | 50.71 Million | 617.75 Million | 340.63 Million | 4.45 Million |
| Debt repayment | -97.93 Million | -553.61 Million | - | - | - | -1.69 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 21.33 Million | 8.19 Million | 50.71 Million | 617.75 Million | 340.75 Million | 6.42 Million |
| Other Financing Activities | -44 Thousand | 1.1 Billion | 50.71 Million | 617.75 Million | 340.63 Million | -281 Thousand |
| Accounts receivables | -7.65 Million | 1.57 Million | -18.14 Million | -6.38 Million | -599 Thousand | 198 Thousand |
| Accounts payables | 1.88 Million | -5.81 Million | 4.22 Million | -791 Thousand | 1.44 Million | -445 Thousand |
| Inventory | -4.36 Million | -8.92 Million | -12.56 Million | -6.7 Million | 8.97 Million | - |
| Other working capital | -30.98 Million | -40.6 Million | 2.8 Million | -1.73 Million | -94 Thousand | 31.68 Million |
| Cash at beginning of period | 119.7 Million | 215.11 Million | 689.8 Million | 119.6 Million | 73.42 Million | 405.07 Million |
| Cash at end of period | 71.28 Million | 124.9 Million | 215.11 Million | 689.8 Million | 119.6 Million | 73.42 Million |
| Capital Expenditure | -16.06 Million | -8.91 Million | -261.24 Million | -3.15 Million | -14.01 Million | -12.67 Million |
| Effect of forex changes on cash | 202 Thousand | -207 Thousand | -888 Thousand | -345 Thousand | 18 Thousand | - |
| Net cash flow / Change in cash | -48.42 Million | -90.21 Million | -474.68 Million | 570.2 Million | 46.17 Million | -331.64 Million |
| Free Cash Flow | -452.9 Million | -511.19 Million | -559.89 Million | 383.87 Million | -292.02 Million | -187.68 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56.27 Million | -49.99 Million | 89.13 Million | -110.91 Million | -506.98 Million | -133.71 Million |
| Depreciation & Amortization | 3.86 Million | 3.61 Million | 4.81 Million | 1.53 Million | 11.66 Million | 2.87 Million |
| Deferred income taxes | - | - | - | -28.88 Million | 23.2 Million | -11.52 Million |
| Stock-based compensation | 28.28 Million | 28.02 Million | 24.22 Million | 22.58 Million | 92.67 Million | 23.07 Million |
| Change in working capital | 15.46 Million | -26.8 Million | -43.2 Million | 10.4 Million | -41.12 Million | 2.97 Million |
| Other non-cash items | -4.97 Million | -2.9 Million | -128.3 Million | 26.35 Million | -16.27 Million | 11.84 Million |
| Investing Cash Flow | 29.95 Million | -188.29 Million | 77.13 Million | 78.76 Million | 274.04 Million | -9.58 Million |
| Investments in PPE | -25 Thousand | -2.56 Million | -1.1 Million | -4.67 Million | -16.06 Million | -6.25 Million |
| Acquisitions | - | - | - | -83.44 Million | - | 3.33 Million |
| Investment purchases | -201.02 Million | -355.47 Million | -200.16 Million | -117.65 Million | -766.36 Million | -240.93 Million |
| Sales/Maturities of investments | 231 Million | 169.75 Million | 278.4 Million | 201.1 Million | 1.05 Billion | 237.6 Million |
| Other Investing Activities | - | - | 78.23 Million | 83.44 Million | 1.00 | -3.33 Million |
| Financing Cash Flow | 18.37 Million | 178.01 Million | 66.96 Million | 15.52 Million | 119.22 Million | 98.39 Million |
| Debt repayment | -147.34 Million | -146.97 Million | -369 Thousand | -35 Thousand | -97.93 Million | -97.96 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -98.54 Million | 31.21 Million | 67.33 Million | 15.6 Million | 21.33 Million | 431 Thousand |
| Other Financing Activities | 18.37 Million | - | -369 Thousand | -44 Thousand | 195.82 Million | 195.93 Million |
| Accounts receivables | 19.89 Million | -25.06 Million | -17.33 Million | -1.7 Million | -7.65 Million | -5.86 Million |
| Accounts payables | 3.21 Million | -82 Thousand | 313 Thousand | -2.36 Million | 1.88 Million | 26 Thousand |
| Inventory | -4.06 Million | -4.68 Million | 2.69 Million | 829 Thousand | -4.36 Million | 2.91 Million |
| Other working capital | -362 Thousand | 3.02 Million | -28.87 Million | 13.64 Million | -30.98 Million | 5.89 Million |
| Cash at beginning of period | 65.57 Million | 113.32 Million | 71.28 Million | 55.97 Million | 119.7 Million | 81.87 Million |
| Cash at end of period | 100.85 Million | 54.77 Million | 113.32 Million | 71.28 Million | 71.28 Million | 65.66 Million |
| Capital Expenditure | -25 Thousand | -2.56 Million | -1.1 Million | -4.67 Million | -16.06 Million | -6.25 Million |
| Effect of forex changes on cash | 591 Thousand | -31 Thousand | -145 Thousand | 487 Thousand | 202 Thousand | -541 Thousand |
| Net cash flow / Change in cash | 35.28 Million | -58.55 Million | 42.04 Million | 15.31 Million | -48.42 Million | -16.21 Million |
| Free Cash Flow | -13.66 Million | -50.64 Million | -102.61 Million | -83.6 Million | -452.9 Million | -110.73 Million |
0058
ENTRA
ABANF
INDSILHYD
LAFFANSQ
AIM